» Articles » PMID: 32345661

Caspase-1 Cleaves Bid to Release Mitochondrial SMAC and Drive Secondary Necrosis in the Absence of GSDMD

Overview
Date 2020 Apr 30
PMID 32345661
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Caspase-1 drives a lytic inflammatory cell death named pyroptosis by cleaving the pore-forming cell death executor gasdermin-D (GSDMD). deficiency, however, only delays cell lysis, indicating that caspase-1 controls alternative cell death pathways. Here, we show that in the absence of GSDMD, caspase-1 activates apoptotic initiator and executioner caspases and triggers a rapid progression into secondary necrosis. GSDMD-independent cell death required direct caspase-1-driven truncation of Bid and generation of caspase-3 p19/p12 by either caspase-8 or caspase-9. tBid-induced mitochondrial outer membrane permeabilization was also required to drive SMAC release and relieve inhibitor of apoptosis protein inhibition of caspase-3, thereby allowing caspase-3 auto-processing to the fully active p17/p12 form. Our data reveal that cell lysis in inflammasome-activated -deficient cells is caused by a synergistic effect of rapid caspase-1-driven activation of initiator caspases-8/-9 and Bid cleavage, resulting in an unusually fast activation of caspase-3 and immediate transition into secondary necrosis. This pathway might be advantageous for the host in counteracting pathogen-induced inhibition of GSDMD but also has implications for the use of GSDMD inhibitors in immune therapies for caspase-1-dependent inflammatory disease.

Citing Articles

PANoptosis in autoimmune diseases interplay between apoptosis, necrosis, and pyroptosis.

Liu K, Wang M, Li D, Duc Duong N, Liu Y, Ma J Front Immunol. 2024; 15:1502855.

PMID: 39544942 PMC: 11560468. DOI: 10.3389/fimmu.2024.1502855.


Inflammasome-mediated pyroptosis in defense against pathogenic bacteria.

Oh C, Spears T, Aachoui Y Immunol Rev. 2024; 329(1):e13408.

PMID: 39404258 PMC: 11741929. DOI: 10.1111/imr.13408.


Role of Pyroptosis in Endometrial Cancer and Its Therapeutic Regulation.

Al Mamun A, Geng P, Wang S, Shao C J Inflamm Res. 2024; 17:7037-7056.

PMID: 39377044 PMC: 11457779. DOI: 10.2147/JIR.S486878.


Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives.

Hu D, Sheeja Prabhakaran H, Zhang Y, Luo G, He W, Liou Y Crit Care. 2024; 28(1):292.

PMID: 39227925 PMC: 11373266. DOI: 10.1186/s13054-024-05069-w.


Multiple sclerosis: the NLRP3 inflammasome, gasdermin D, and therapeutics.

Brint A, Greene S, Fennig-Victor A, Wang S Ann Transl Med. 2024; 12(4):62.

PMID: 39118955 PMC: 11304424. DOI: 10.21037/atm-23-1960.


References
1.
Kanneganti A, Malireddi R, Saavedra P, Vande Walle L, Van Gorp H, Kambara H . GSDMD is critical for autoinflammatory pathology in a mouse model of Familial Mediterranean Fever. J Exp Med. 2018; 215(6):1519-1529. PMC: 5987922. DOI: 10.1084/jem.20172060. View

2.
Monteleone M, Stanley A, Chen K, Brown D, Bezbradica J, von Pein J . Interleukin-1β Maturation Triggers Its Relocation to the Plasma Membrane for Gasdermin-D-Dependent and -Independent Secretion. Cell Rep. 2018; 24(6):1425-1433. DOI: 10.1016/j.celrep.2018.07.027. View

3.
Verhagen A, Ekert P, Pakusch M, Silke J, Connolly L, Reid G . Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell. 2000; 102(1):43-53. DOI: 10.1016/s0092-8674(00)00009-x. View

4.
Lee B, Mirrashidi K, Stowe I, Kummerfeld S, Watanabe C, Haley B . ASC- and caspase-8-dependent apoptotic pathway diverges from the NLRC4 inflammasome in macrophages. Sci Rep. 2018; 8(1):3788. PMC: 5830643. DOI: 10.1038/s41598-018-21998-3. View

5.
Roy N, Deveraux Q, Takahashi R, Salvesen G, Reed J . The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 1998; 16(23):6914-25. PMC: 1170295. DOI: 10.1093/emboj/16.23.6914. View